Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise on Tapering Antipsychotics in Psycho-Cardiological Disease
NCT07025590Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Dosage of anti-anxiety/depression drugs at 12 weeks. Started Apr 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07025590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07025590.